Researchers at Massachusetts Eye and Ear/Harvard Medical School and Boston University have successfully shown neuroprotection in a Parkinson’s mouse model using new techniques to deliver drugs across the naturally impenetrable blood-brain barrier. Their findings, published in Neurosurgery, lend hope to patients around the world with neurological conditions that are difficult to treat due to a barrier mechanism that prevents approximately 98 percent of drugs from reaching the brain and central nervous system.
“We are developing a platform that may eventually be used to deliver a variety of drugs to the brain,” said senior author Benjamin S. Bleier, M.D. (in photo), of the department of otolaryngology at Mass. Eye and Ear/Harvard Medical School. “Although we are currently looking at neurodegenerative disease, there is potential for the technology to be expanded to psychiatric diseases, chronic pain, seizure disorders and many other conditions affecting the brain and nervous system down the road.”
Using nasal mucosal grafting, researchers delivered glial derived neurotrophic factor (GDNF), a therapeutic protein in testing for treating Parkinson’s disease, to the brains of mice. They showed through behavioral and histological data capture that their delivery method was equivalent to direct injection of GDNF – the current gold standard for delivering this drug in Parkinson’s disease despite its traumatic nature and high complication rates – in diffusing drugs to the brain.
The researchers chose to test their delivery method with GDNF because the therapy has been shown to delay and even reverse disease progression of Parkinson’s disease in pre-clinical models. The study was funded by The Michael J. Fox Foundation for Parkinson’s Research (MJFF).
“Brain diseases are notoriously difficult to treat due to the natural protections the body builds against intrusion,” said Jamie Eberling, Ph.D., senior associate director of MJFF research programs. “Dr. Bleier’s group has identified a potential avenue to pass that barrier, and we look forward to the next stage of research to further test its utility in people with Parkinson’s disease .”
Nasal mucosal grafting is a technique regularly used in the ENT field to reconstruct the barrier around the brain after surgery to the skull base. ENT surgeons commonly use endoscopic approaches to remove brain tumors through the nose by making a window through the blood-brain barrier to access the brain. Once they have finished the treatment, they use adjacent nasal lining to rebuild the hole in a permanent and safe way. The safety and efficacy of these methods have been well established through long-term clinical outcomes studies in the field, with the nasal lining protecting the brain from infection just as the blood brain barrier has done.
Dr. Bleier saw an opportunity to apply these techniques to the widespread clinical dilemma of delivering drugs across the barrier to the brain and central nervous system. By functionally replacing a section of the blood-brain barrier with nasal mucosa, which is more than 1,000 times more permeable than the native barrier, surgeons may create a “screen door” to allow for drug delivery to the brain and central nervous system.
The technique has the potential to benefit a large population of patients with neurodegenerative disorders, where there remains a specific unmet need for blood-brain penetrating therapeutic delivery strategies.
“We see this expanding beyond Parkinson’s disease, as there are multiple diseases of the brain that do not have good therapeutic options,” Dr. Bleier said. “It is a platform that opens doors for new discovery and could enable drug development for an underserved population.”
The Latest on: neurodegenerative disorders
via Google News
The Latest on: neurodegenerative disorders
- Leveraging Neuroimaging for the Diagnosis of Psychiatric and Neurodegenerative Diseases on May 24, 2019 at 4:50 am
SAN FRANCISCO — A number of psychiatric and neurodegenerative diseases are associated with abnormal imaging findings, which can help psychiatrists reach a diagnosis, according to research presented at ... […]
- Study Finds Relationship Between Appendix Removal and Higher Risk of Parkinson’s Disease on May 23, 2019 at 7:48 am
The investigation, to be presented on Monday, May 20, 2019, during Digestive Disease Week in San Diego, adds to a growing body of evidence demonstrating that gastrointestinal issues may be connected ... […]
- Amido-bridged nucleic acid (AmNA)-modified antisense oligonucleotides targeting α-synuclein as a novel therapy for Parkinson’s disease on May 20, 2019 at 3:17 pm
Parkinson’s disease (PD) is a neurodegenerative disease caused by the loss of dopaminergic neurons in the nigrostriatal pathway 1. Clinical manifestations of PD include bradykinesia, muscular rigidity ... […]
- Alector: Targeted Therapies For Neurodegenerative Diseases on May 20, 2019 at 9:43 am
Shares have risen slightly since February IPO. Alector is taking a unique approach in treating neurodegenerative disease by empowering the immune system to attain a cure. Management team seems ... […]
- Imaging techniques shed light on amyloid fibrils associated with Alzheimer’s disease on May 20, 2019 at 8:37 am
The team used a near-infrared signal from the fibrils to identify the presence of amyloid structures in the brains of live mice and believe that their method could form the basis of a clinical test ... […]
- Lifetime Achievement: DeLong's discoveries revolutionized understanding of Parkinson's disease on May 17, 2019 at 3:45 am
Parkinson’s disease is a neurodegenerative disorder that can cause tremors and limb rigidity, as well as problems with balance and walking. His work defining and characterizing the circuits in the ... […]
- Parkinson’s Disease Shocker: Can Removing Appendix Cause Neurodegenerative Disorder? on May 14, 2019 at 8:00 pm
If you need an appendectomy, get one, and don’t worry about the bizarre news that suggests the risk of developing Parkinson's disease increases if one were to undergo an appendectomy. A new but ... […]
- Study Shows How Mutations Lead to Neurodegenerative Diseases on May 14, 2019 at 3:45 pm
Mutations in DNA can cause neurodegenerative diseases namely Huntington's and motor neurone, said researchers. The discovery is an important step towards better treatment to slow the progression or ... […]
- Scientists discover how mutations in DNA can cause neurodegenerative disease on May 13, 2019 at 7:13 am
Scientists have discovered how mutations in DNA can cause neurodegenerative disease. The discovery is an important step towards better treatment to slow the progression or delay onset in a range of ... […]
- Ben-Gurion University Introduces Novel Combination Therapy for Treating Neurological Disorders on May 13, 2019 at 5:11 am
Disruption of the BBB plays an important role in cellular damage in neurological diseases, including stroke, neurodegenerative diseases, brain tumors, and brain infections. BBB breakdown allows ... […]
via Bing News